Mansi joined Nvelop as Sr. Director of Corporate Development & Strategy in August of 2022. She leads business development, portfolio strategy and PR. Prior to Nvelop, Mansi led strategy and operations at Diagon Therapeutics, a 5AM Ventures NewCo focused on iPSC-derived cell therapies that she helped conceive. Mansi was also an Operating Associate at 5AM Ventures where she focused on scientific diligence and company creation, building and strategy. Earlier in her career, Mansi was a consultant at Health Advances where she advised biotech and pharmaceutical companies on corporate and business development, pipeline and portfolio strategy, clinical development, and commercialization.

Mansi received her Ph.D. in Pharmacology from the University of Pennsylvania and her B.A. in Biology and Business from New York University.

Favorite Activity: Trying new restaurants and attempting to recreate her favorite dishes at home